Variable | OR | 95% CI | P value |
Multiple logistic regression analysis: Outcomevariable=AllLAMS-associated adverse events | |||
Age: ≥60 vs <60 years | 1.23 | 0.33 to 4.63 | 0.762 |
Gender: Male vs Female | 0.91 | 0.24 to 3.49 | 0.888 |
Race: Caucasian vs Non-Caucasian | 0.96 | 0.18 to 5.28 | 0.966 |
PFC type: Necrotic collection vs Pseudocyst | 0.79 | 0.13 to 4.86 | 0.802 |
PFC size: ≤7 vs >7 cm | 5.80 | 1.34 to 25.0 | 0.019 |
PFC location: Tail involved vs Tail not involved | 1.15 | 0.21 to 6.40 | 0.871 |
Degree of necrosis: ≤40 vs>40% | 1.52 | 0.30 to 7.61 | 0.608 |
Route of drainage: Proximal stomach vs Other | 1.95 | 0.37 to 10.3 | 0.431 |
CT severity index: ≥8 vs <8 | 1.07 | 0.18 to 6.20 | 0.943 |
ASA: III/IV vs I/II | 2.80 | 0.63 to 12.4 | 0.174 |
Time to LAMS removal: >4 vs ≤4 weeks | 4.93 | 1.27 to 19.1 | 0.021 |
Reverse stepwise multivariate logistic regression analysis: Outcomevariable=AllLAMS-associated adverse events | |||
PFC size: ≤7 vs >7 cm | 4.33 | 1.10 to 17.0 | 0.036 |
Time to LAMS removal: >4 vs ≤4 weeks | 4.60 | 1.30 to 16.3 | 0.018 |
Multiplepenalisedlogistic regression with Firth’s correction: Outcomevariable=LAMSassociated bleeding only | |||
Age: ≥60 vs <60 years | 1.14 | 0.24 to 5.37 | 0.866 |
Gender: Male vs Female | 0.34 | 0.07 to 1.74 | 0.197 |
Race: Caucasian vs Non-Caucasian | 11.1 | 0.32 to 382.9 | 0.182 |
PFC type: Necrotic collection vs Pseudocyst | 0.25 | 0.02 to 3.12 | 0.283 |
PFC size: ≤7 vs >7 cm | 42.4 | 2.28 to 787.8 | 0.012 |
PFC location: Tail involved vs Tail not involved | 0.96 | 0.10 to 9.07 | 0.975 |
Degree of necrosis: ≤40 vs >40% | 1.25 | 0.23 to 6.83 | 0.795 |
Route of drainage: Proximal stomach vs Other | 5.76 | 0.79 to 41.9 | 0.084 |
CT severity index: ≥8 vs <8 | 2.75 | 0.30 to 25.5 | 0.372 |
ASA: III/IV vs I/II | 3.35 | 0.56 to 20.1 | 0.186 |
Time to LAMS removal: >4 vs ≤4 weeks | 1.54 | 0.35 to 6.78 | 0.566 |
ASA, American Society of Anesthesiologists; LAMS, lumen-apposing metal stent; PFC, pancreatic fluid collection.